Review of Chronic Graft-Versus-Host Disease in Children After Allogeneic Stem Cell Transplantation: Nursing Perspective

被引:3
|
作者
Liu, Ying-Mei [1 ]
Hockenberry, Marilyn [1 ]
机构
[1] Chang Gung Univ, Dept Nursing, Chang Gung Inst Technol, Grad Inst Clin Med Sci, Tao Yuan 33302, Taiwan
关键词
allogeneic hematopoietic stem cell transplantation; chronic graft-versus-host disease; children; incidence; risk factors; BONE-MARROW-TRANSPLANTATION; CORD BLOOD TRANSPLANTATION; CONSENSUS DEVELOPMENT PROJECT; ACUTE LYMPHOBLASTIC-LEUKEMIA; RISK-FACTORS; T-CELLS; SUPPORTIVE CARE; CLINICAL-TRIALS; DONOR; PROPHYLAXIS;
D O I
10.1177/1043454210377177
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This review presents a summary of the research literature related to the incidence and risk factors for chronic graft-versus-host disease in children following allogeneic hematopoietic stem cell transplantation. The range of incidence of chronic graft-versus-host disease in children found in this review was large, from 0% to 46%. Incidence of chronic graft-versus-host disease was influenced by sample size, time posttransplantation, and stem cell source. Characteristics of the person (eg, child's age and gender) and disease/treatment (eg, sources of transplant) are associated with chronic graft-versus-host disease in children after stem cell transplantation. Person and disease/treatment characteristics provide a framework for understanding the factors associated with chronic graft-versus-host disease symptom experiences in children after stem cell transplantation. Timely assessment of presenting chronic graft-versus-host disease symptoms is critical for treatment and prognosis. Nursing interventions should focus on educating children and parents about the signs and symptoms of chronic graft-versus-host disease. The summary of supportive nursing care for children with chronic graft-versus-host disease provides important information to tailor effective management strategies for children with chronic graft-versus-host disease.
引用
收藏
页码:6 / 15
页数:10
相关论文
共 50 条
  • [31] Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Nassar, Amr
    Elgohary, Ghada
    Elhassan, Tusneem
    Nurgat, Zubeir
    Mohamed, Said Y.
    Aljurf, Mahmoud
    JOURNAL OF TRANSPLANTATION, 2014, 2014
  • [32] Serum catalase to predict graft-versus-host disease after allogeneic stem cell transplantation
    Kircher, B.
    Schumacher, P.
    Clausen, J.
    Auberger, J.
    Nachbaur, D.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S118 - S118
  • [33] Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Chen, Yi-Bin
    Shah, Nirav N.
    Renteria, Anne S.
    Cutler, Corey
    Jansson, Johan
    Akbari, Mona
    Chen, Chunlin
    Quadri, Syed
    Parfionovas, Andrejus
    Devine, Steven M.
    BLOOD ADVANCES, 2019, 3 (23) : 4136 - 4146
  • [34] Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplantation
    Quellmann, Susanne
    Schwarzer, Guido
    Huebel, Kai
    Greb, Alexander
    Engert, Andreas
    Bohlius, Julia
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (03):
  • [35] Proteomic patterns and graft-versus-host disease after allogeneic haematopoietic stem cell transplantation
    Chiusolo, P.
    Bellesi, S.
    Fanali, C.
    Giammarco, S.
    Sica, S.
    Inzitari, R.
    Iavarone, F.
    Leone, G.
    Castagnola, M.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S13 - S13
  • [36] Invasive zygomycosis in patients with graft-versus-host disease after allogeneic stem cell transplantation
    Leithauser, M.
    Kahl, C.
    Aepinus, C.
    Prall, F.
    Maruschke, M.
    Riemer, H.
    Wolff, D.
    Jost, K.
    Hilgendorf, I.
    Freund, M.
    Junghanss, C.
    TRANSPLANT INFECTIOUS DISEASE, 2010, 12 (03) : 251 - 257
  • [37] Graft-versus-host disease induced by tisagenlecleucel in patients after allogeneic stem cell transplantation
    Gabelli, Maria
    Marks, David I.
    Sharplin, Kirsty
    Lazareva, Arina
    Mullanfiroze, Khushnuma
    Farish, Susan
    Burridge, Saskia
    Velangi, Mark
    Rampling, Dyanne
    Mozayani, Behrang
    Chiesa, Robert
    Lucchini, Giovanna
    Samarasinghe, Sujith
    Bartram, Jack
    Ghorashian, Sara
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (05) : 805 - 811
  • [38] Late Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Omer, Aazim K.
    Weisdorf, Daniel J.
    Lazaryan, Aleksandr
    Shanley, Ryan
    Blazar, Bruce R.
    MacMillan, Margaret L.
    Brunstein, Claudio
    Bejanyan, Nelli
    Arora, Mukta
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (05) : 879 - 883
  • [39] Interleukin-22 in Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation
    Lamarthee, Baptiste
    Malard, Florent
    Saas, Philippe
    Mohty, Mohamad
    Gaugler, Beatrice
    FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [40] Acute and chronic Graft-versus-host disease after hematopoietic stem cell transplantation
    Funke, Vaneuza A. M.
    Rodrigues Moreira, Maria Claudia
    Vigorito, Afonso Celso
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2016, 62 : 44 - 50